Type 1 PCV (n=16) | Type 2 PCV (n=13) | p Value | |
---|---|---|---|
Age (years)* | 69.7±7.4 | 64.2±6.6 | 0.068† |
Sex (male:female) | 11:5 | 12:1 | 0.136‡ |
BCVA (logMAR)* | 0.76±0.41 | 0.62±0.30 | 0.288† |
Largest polyp diameter (μm)* | 263.5±104.3 | 240.1±78.7 | 0.527† |
GLD (μm)* | 2968±1034 | 2526±1171 | 0.351† |
Polyp number* | 3.8±2.2 | 1.6±0.8 | 0.001† |
BVN leakage (present:absent) | 14:2 | 6:7 | 0.023‡ |
Largest PED height (μm)* | 438.8±299.5 | 313.1±174.5 | 0.268† |
CMT (μm)* | 461.2±102.1 | 416.1±83.6 | 0.249† |
Subfoveal CT (μm)* | 206.9±57.8 | 275.1±82.5 | 0.015† |
*Data are presented as mean±SD.
†p Value using the Mann–Whitney test.
‡p Value using Fisher's exact test.
BCVA, best-corrected visual acuity; BVN, branch vascular network; CMT, central macular thickness; CT, choroidal thickness; GLD, greatest linear dimension; logMAR, logarithm of the minimum angle of resolution; PCV, polypoidal choroidal vasculopathy; PED, pigment epithelial detachment.